Gene identification of L-alanine-3-formylquinuclidine aminotransferase from Brevibacterium aurantiacum NBRC 12171

Clicks: 23
ID: 329656
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #39 of 98 articles by views in bioscience biotechnology and biochemistry

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Quinuclidine derivatives are promising pharmaceutical agents. Herein, we screened for microorganisms capable of converting 3-formylquinuclidine and found that Brevibacterium aurantiacum NBRC 12171 converted 3-formylquinuclidine into quinuclidin-3-ylmethanamine. Through enzyme purification and the heterologous expression of candidate genes, the L-alanine-3-formylquinuclidine aminotransferase gene was identified. Using purified recombinant L-alanine-3-formylquinuclidine aminotransferase, we identified L-alanine as an amino donor for the conversion of 3-formylquinuclidine to quinuclidin-3-ylmethanamine. These findings provide a potential biocatalytic approach for the sustainable production of quinuclidine-based pharmaceutical building blocks.
Reference Key
openalex_W7214168475 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal bioscience biotechnology and biochemistry
Year 2026
DOI
10.1093/bbb/zbag143
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.